TherapeuticsMD (TXMD) Gross Profit Growth (5y) (2016 - 2023)
Powered by 
Analysis
TherapeuticsMD (TXMD) Gross Profit Growth (5y) (2016 - 2023) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 650.65 Bn | 629.89 Bn | 17.26 Bn |
| 2 | AbbVie | 466.34 Bn | 459.82 Bn | 12.70 Bn |
| 3 | Merck | 362.11 Bn | 355.02 Bn | 12.21 Bn |
| 4 | Novartis Ag | 267.81 Bn | 260.52 Bn | 11.24 Bn |
| 5 | Pfizer | 157.31 Bn | 145.91 Bn | 10.94 Bn |
| 6 | Bristol Myers Squibb | 128.75 Bn | 117.69 Bn | 9.25 Bn |
| 7 | Sanofi | 51.80 Bn | 44.84 Bn | 10.79 Bn |
| 8 | Revolution Medicines | 40.91 Bn | 40.91 Bn | - |
| 9 | BeOne Medicines | 39.65 Bn | 34.55 Bn | 1.53 Bn |
| 10 | TherapeuticsMD | 25.35 Mn | 16.16 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2023 | -34.42% |
| Sep 30, 2023 | -15.09% |
| Jun 30, 2023 | -33.30% |
| Mar 31, 2023 | -33.25% |
| Dec 31, 2022 | 81.00% |
| Mar 31, 2022 | 34.19% |
| Dec 31, 2021 | 29.84% |
| Sep 30, 2021 | 36.17% |
| Jun 30, 2021 | 41.96% |
| Mar 31, 2021 | 31.76% |
| Dec 31, 2020 | 31.06% |
| Sep 30, 2020 | 32.08% |
| Jun 30, 2020 | 10.56% |
| Mar 31, 2020 | 22.68% |
| Dec 31, 2019 | 30.99% |
| Sep 30, 2019 | 48.18% |
| Jun 30, 2019 | 11.06% |
| Mar 31, 2019 | 9.75% |
| Dec 31, 2018 | 344.10% |
| Sep 30, 2018 | 341.94% |